A detailed history of Chi Advisors LLC transactions in Graphite Bio, Inc. stock. As of the latest transaction made, Chi Advisors LLC holds 230,938 shares of GRPH stock, worth $0. This represents 0.28% of its overall portfolio holdings.

Number of Shares
230,938
Previous 230,938 -0.0%
Holding current value
$0
Previous $600,000 4.67%
% of portfolio
0.28%
Previous 0.23%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

BUY
$2.47 - $3.38 $570,416 - $780,570
230,938 New
230,938 $600,000

Others Institutions Holding GRPH

About Graphite Bio, Inc.


  • Ticker GRPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,211,200
  • Description
  • Graphite Bio, Inc., a clinical-stage gene editing company, engages in developing therapies for serious and life-threatening diseases in the United States. It offers GPH101, a gene-edited autologous hematopoietic stem cell product candidate to directly correct the mutation that causes sickle cell disease and restore normal adult hemoglobin expres...
More about GRPH
Track This Portfolio

Track Chi Advisors LLC Portfolio

Follow Chi Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chi Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chi Advisors LLC with notifications on news.